Aliases & Classifications for Hydrarthrosis

MalaCards integrated aliases for Hydrarthrosis:

Name: Hydrarthrosis 12 45 15 74

Classifications:



External Ids:

Disease Ontology 12 DOID:528
ICD9CM 36 719.08
MeSH 45 D006833

Summaries for Hydrarthrosis

MalaCards based summary : Hydrarthrosis is related to synovitis and osteoarthritis, and has symptoms including arthralgia, edema and metatarsalgia. An important gene associated with Hydrarthrosis is MEFV (MEFV Innate Immuity Regulator, Pyrin), and among its related pathways/superpathways are Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds and Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. The drugs Liraglutide and Methylprednisolone have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and brain, and related phenotypes are homeostasis/metabolism and skeleton

Related Diseases for Hydrarthrosis

Diseases related to Hydrarthrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)
# Related Disease Score Top Affiliating Genes
1 synovitis 29.9 IL1B IL1RN MMP13 MMP3
2 osteoarthritis 29.4 ADAMTS5 IL1B MMP13 MMP3
3 arthritis 28.9 ADAMTS5 IL1B IL1RN MMP13 MMP3
4 intermittent hydrarthrosis 12.6
5 dysferlinopathy 10.3 AQP1 MIP
6 impaired renal function disease 10.3 AQP1 AQP3
7 familial cold autoinflammatory syndrome 1 10.3 IL1B MEFV
8 cervical adenitis 10.3 IL1B MEFV
9 hypersensitivity reaction type iii disease 10.2 C4A MEFV
10 juvenile ankylosing spondylitis 10.2 IL1RN MEFV
11 diabetes insipidus, nephrogenic, autosomal 10.2 AQP1 AQP3 MIP
12 corneal ulcer 10.2 IL1B MMP3
13 peritonitis 10.1 AQP1 IL1B MEFV
14 blau syndrome 10.1 IL1B MEFV
15 pericardium disease 10.1 IL1RN MEFV
16 brain edema 10.1 AQP1 IL1B MIP
17 corneal edema 10.1 IL1B MMP3
18 pharyngitis 10.1 IL1B MEFV
19 vulvar vestibulitis syndrome 10.1 IL1B IL1RN
20 schnitzler syndrome 10.1 IL1B IL1RN
21 osteosclerotic myeloma 10.1 IL1B IL1RN
22 multicentric reticulohistiocytosis 10.1
23 familial calcium pyrophosphate deposition 10.1
24 meningococcemia 10.1 IL1B IL1RN
25 hypersensitivity vasculitis 10.0 C4A MEFV PRTN3
26 meniere disease 10.0 AQP1 AQP3 AQP7 MIP
27 muckle-wells syndrome 10.0 IL1B MEFV
28 cinca syndrome 10.0 IL1B IL1RN MEFV
29 adult-onset still's disease 10.0 IL1B IL1RN MEFV
30 palindromic rheumatism 10.0 IL1B MEFV PRTN3
31 aphthous stomatitis 10.0 IL1B IL1RN MEFV
32 sorsby fundus dystrophy 10.0 MMP13 MMP3
33 bone deterioration disease 10.0 IL1B MMP13 MMP3
34 pericarditis 10.0 IL1B IL1RN MEFV
35 familial mediterranean fever 10.0 IL1B IL1RN MEFV
36 joint disorders 10.0 IL1B IL1RN MMP3
37 frozen shoulder 10.0 ASIC2 ASIC3 IL1B MMP3
38 anterior scleritis 9.9 IL1RN PRTN3
39 periodontal disease 9.9 IL1B IL1RN MMP3
40 glomerulonephritis 9.9 C4A IL1B PRTN3
41 behcet syndrome 9.8 C4A IL1B IL1RN MEFV
42 aseptic meningitis 9.7 IL1B IL1RN
43 bone structure disease 9.5 ADAMTS5 IL1B MMP13 MMP3
44 rheumatoid arthritis 9.4 IL1B IL1RN MMP13 MMP3 PRTN3
45 bone inflammation disease 8.9 ADAMTS5 IL1B IL1RN MMP13 MMP3 PRTN3

Graphical network of the top 20 diseases related to Hydrarthrosis:



Diseases related to Hydrarthrosis

Symptoms & Phenotypes for Hydrarthrosis

UMLS symptoms related to Hydrarthrosis:


arthralgia, edema, metatarsalgia, other symptoms referable to joint, stiffness of joint, not elsewhere classified in icd10cm, painful swollen joints, effusion of joint, other specified sites

MGI Mouse Phenotypes related to Hydrarthrosis:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.65 AQP1 AQP3 AQP7 AQP9 ASIC3 IL1B
2 skeleton MP:0005390 9.23 ADAMTS5 AQP1 AQP3 IL1B IL1RN MEFV

Drugs & Therapeutics for Hydrarthrosis

Drugs for Hydrarthrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 105)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Liraglutide Approved Phase 4 204656-20-2 44147092
2
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
3
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
4
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
5
Infliximab Approved Phase 4 170277-31-3
6
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
7
Glucosamine Approved, Investigational Phase 4 3416-24-8 439213
8
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
9
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
10 Hormone Antagonists Phase 4
11 Hormones Phase 4,Phase 3,Phase 1
12 Hypoglycemic Agents Phase 4
13 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
14 Incretins Phase 4
15 Antineoplastic Agents, Hormonal Phase 4
16 Peripheral Nervous System Agents Phase 4
17 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
18 Anti-Inflammatory Agents Phase 4,Phase 3
19 Antiemetics Phase 4
20 Prednisolone acetate Phase 4
21 glucocorticoids Phase 4
22 Autonomic Agents Phase 4
23 Methylprednisolone Acetate Phase 4
24 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
25 Protective Agents Phase 4,Phase 1,Not Applicable
26 Gastrointestinal Agents Phase 4,Phase 3
27 Neuroprotective Agents Phase 4
28 Analgesics Phase 4
29
Chondroitin Phase 4 9007-27-6 53477707
30 Anti-Inflammatory Agents, Non-Steroidal Phase 4
31 Analgesics, Non-Narcotic Phase 4
32 Cyclooxygenase Inhibitors Phase 4
33 Cyclooxygenase 2 Inhibitors Phase 4
34
leucovorin Approved Phase 3,Phase 2,Phase 1,Not Applicable 58-05-9 143 6006
35
Methotrexate Approved Phase 3,Phase 2,Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
36
Abatacept Approved Phase 3 332348-12-6 10237
37
Aluminum hydroxide Approved, Investigational Phase 3 21645-51-2
38
Formaldehyde Approved, Vet_approved Phase 3 50-00-0 712
39
Adalimumab Approved Phase 3 331731-18-1 16219006
40
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1,Not Applicable 59-30-3 6037
41
Calcium Approved, Nutraceutical Phase 3,Phase 1 7440-70-2 271
42
Vitamin D3 Approved, Nutraceutical Phase 3 67-97-0 5280795 6221
43
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
44
Ergocalciferol Approved, Nutraceutical Phase 3 50-14-6 5280793
45 Antimetabolites Phase 3,Phase 2,Phase 1,Not Applicable
46 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
47 Folate Phase 3,Phase 2,Phase 1,Not Applicable
48 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1,Not Applicable
49 Vitamin B9 Phase 3,Phase 2,Phase 1,Not Applicable
50 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show all 44)
# Name Status NCT ID Phase Drugs
1 Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance Completed NCT02931383 Phase 4 Liraglutide 3 mg (Saxenda);Liraglutide 3 mg placebo
2 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Completed NCT01144143 Phase 4 Infliximab;Placebo;Standard of Care: Methylprednisolone acetate
3 Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis Completed NCT01425853 Phase 4 Chondroitin/Glucosamine (Droglican);Celecoxib
4 A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography Completed NCT00767325 Phase 3 Abatacept;Methotrexate
5 Ross River Virus (RRV) Vaccine Study Completed NCT01242670 Phase 3
6 VItamin D Effect on Osteoarthritis Study Completed NCT01176344 Phase 3 Vitamin D;Placebo
7 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease Completed NCT00195715 Phase 3
8 Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis Recruiting NCT02837146 Phase 3 Methotrexate (MTX)
9 Somatosensory Stimulation in Knee Osteoarthritis Unknown status NCT02854176 Phase 2
10 Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee Unknown status NCT02554240 Phase 2 DA-5202 20mg;DA-5202 10mg;Na Hyaluronate 20mg
11 Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage Completed NCT02219113 Phase 1, Phase 2
12 Effects of Ultrasound Therapy on Cartilage Healing in Patients With Knee Osteoarthritis Completed NCT00931749 Phase 2
13 Based on the Ultrasound Evaluating the Effect of Xiaozhong Fang Particles for Knee Osteoarthritic With Synovial Fluid Recruiting NCT03586700 Phase 2 Xiao zhong fang granules;Placebo Xiao zhong fang granules
14 Effectiveness and Safety of Autologous ADRC for Treatment of Anterior Cruciate Ligament Partial Rupture Enrolling by invitation NCT02469792 Phase 1, Phase 2
15 Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy Enrolling by invitation NCT02827851 Phase 2
16 Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study Terminated NCT02263638 Phase 2 Anakinra
17 Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) Terminated NCT01569152 Phase 2 MK-8457 100 mg;Dose-Matched Placebo;Methotrexate
18 Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma Completed NCT00742924 Phase 1 cisplatin;dexrazoxane hydrochloride;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;zoledronic acid;Mesna
19 Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients Unknown status NCT00658060
20 Determination of Adipocytokine in Synovial Fluid of Osteoarthritis Patients Unknown status NCT01993342
21 Use of Infrared Spectroscopy in Septic Arthritis Diagnosis Completed NCT02860871
22 The Effects of Joint Effusion on Proprioception Completed NCT01060215 Not Applicable
23 Effects of Joint Effusion on Quadriceps Muscle Completed NCT01314820 Not Applicable
24 MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs Completed NCT00584311 Not Applicable
25 Ultrasonography Assessment of Septic Arthritis on Native Joint Completed NCT02018952 Not Applicable
26 Association Between Clinical Signs and MRI Findings of the Lumbar Facet Joints Completed NCT01628939
27 Chikungunya Arthritis in the Americas Completed NCT02463968
28 Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet Completed NCT01677416
29 Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients Completed NCT01850719 Not Applicable
30 Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss Completed NCT02931370
31 Time Difference Between Onsets of Lateral And Medial Hamstring Muscles During Gait in Patients With Patellofemoral Pain. Completed NCT03392688 Not Applicable
32 An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST) Completed NCT01394276
33 Effect of Yogurts Supplemented With Mobilee on Joint Function in Healthy Individuals With Joint Discomfort Completed NCT01303432 Not Applicable
34 Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis Completed NCT03203408 Not Applicable
35 Walking Gait Biomechanics Following Knee Joint Effusion Recruiting NCT03805464 Not Applicable
36 Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis Recruiting NCT03327584 Not Applicable
37 Pilot Trial to Assess the Feasibility of Implementing Objective Parameters in Patients Affected by Knee Osteoarthritis Recruiting NCT03421054 Not Applicable
38 Ultrasonography in Hemophilic Joint Disease and Serum Markers Recruiting NCT02634918
39 INDividualised EXercise for Kneecap Dislocations Recruiting NCT03798483 Not Applicable
40 Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab Active, not recruiting NCT03557853 Golimumab Injection
41 Outcome Study of Highly-cross Linked Polyethylene vs. Standard Polyethylene for Primary Posterior Stabilized (PS) Total Knee Enrolling by invitation NCT02178020
42 Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis Not yet recruiting NCT03815448 Not Applicable Methotrexate
43 Efficacy and Safety of b-2Cool on Adults With Joint Discomfort Withdrawn NCT02843620 Not Applicable
44 Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis Withdrawn NCT00836394 Not Applicable

Search NIH Clinical Center for Hydrarthrosis

Cochrane evidence based reviews: hydrarthrosis

Genetic Tests for Hydrarthrosis

Anatomical Context for Hydrarthrosis

MalaCards organs/tissues related to Hydrarthrosis:

42
Bone, Liver, Brain

Publications for Hydrarthrosis

Articles related to Hydrarthrosis:

(show all 38)
# Title Authors Year
1
Pathological findings from synovium of early osteoarthritic knee joints with persistent hydrarthrosis. ( 24837400 )
2016
2
Successful Treatment of Intermittent Hydrarthrosis With Hydroxychloroquine. ( 26587859 )
2015
3
Boiogito, a Kampo medicine, improves hydrarthrosis in a rat model of knee osteoarthritis. ( 26703073 )
2015
4
Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation. ( 22887853 )
2013
5
May some cases of intermittent hydrarthrosis represent an atypical form of calcium pyrophosphate dihydrate crystal deposition disease? Usefulness of mutational analysis of the MEFV gene. ( 17889261 )
2008
6
Association of intermittent hydrarthrosis with MEFV gene mutations. ( 16802374 )
2006
7
Successful therapy with low-dose colchicine in intermittent hydrarthrosis. ( 12595650 )
2003
8
Multicentric reticulohistiocytosis with hydrarthrosis in both knee joints: disease stabilization with synovectomy, and medication with a steroid and low-dose methotrexate. ( 24383904 )
2002
9
Analysis of synovial fluid components of hydrarthrosis in long-term hemodialysis patients. ( 10370156 )
1999
10
Comparison between clinical evaluation and ultrasonography in detecting hydrarthrosis of the knee. ( 10606382 )
1999
11
Intermittent hydrarthrosis. ( 11273267 )
1998
12
Hydrarthrosis of the knee or ankle revealing metaphyseal stress fractures of the tibia. A report of 3 cases. ( 8523370 )
1995
13
Hyaluronan, cartilage destruction and hydrarthrosis in traumatic arthritis. ( 11548232 )
1994
14
The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV. ( 2098221 )
1990
15
Participation of synovial mast cells in intermittent hydrarthrosis. ( 2467680 )
1989
16
Treatment of hydrarthrosis of the knee with manual manipulation and herbs. ( 3246884 )
1988
17
Calcium pyrophosphate crystals in intermittent hydrarthrosis. ( 3029370 )
1986
18
LE cells in intermittent hydrarthrosis. ( 6157396 )
1980
19
Periodic synoviosis (intermittent hydrarthrosis) with observations and studies on a patient. ( 4464498 )
1974
20
Tarsal hydrarthrosis in the horse: response to intra-articular injection of synthetic steroids. ( 5815590 )
1969
21
Tarsal hydrarthrosis (bog spavin) in the horse: blood, serum, and synovial fluid findings. ( 5688981 )
1968
22
Evaluation of intra-articular injection of synthetic steroids in tarsal hydrarthrosis in cattle. ( 5691642 )
1968
23
Intra-articular injection of 6 alpha-methyl, 17 alpha-hydroxyprogesterone acetate in tarsal hydrarthrosis (bog spavin) in the horse. ( 5624181 )
1967
24
Therapeutic management of tarsal hydrarthrosis (bog spavin) in the horse by intra-articular injection of prednisolone. ( 6068578 )
1967
25
Characteristics of blood, serum, and synovial effusions in cattle with tarsal hydrarthrosis. ( 6069486 )
1967
26
Acute Cervical Hydrarthrosis. ( 19790510 )
1964
27
SYPHILITIC HYDRARTHROSIS. ( 14075738 )
1963
28
Intermittent hydrarthrosis; periodic benign synovitis. ( 13567199 )
1958
29
Intermittent hydrarthrosis. ( 13383213 )
1957
30
Periodic benign synovitis; idiopathic intermittent hydrarthrosis. ( 13367081 )
1956
31
Intermittent hydrarthrosis. ( 14372871 )
1955
32
Hodgkin's disease presenting as hydrarthrosis of knee. ( 14378634 )
1955
33
Intermittent hydrarthrosis. ( 14933539 )
1952
34
Intermittent hydrarthrosis; two cases. ( 15390577 )
1949
35
The roentgenographic appearance of temporomandibular hydrarthrosis. ( 21018447 )
1946
36
Idiopathic Hydrarthrosis. ( 19988486 )
1932
37
Intermittent Hydrarthrosis: (Hydrops Intermittens Articulorum). ( 21433466 )
1930
38
Chronic Hydrarthrosis. ( 19976537 )
1913

Variations for Hydrarthrosis

Expression for Hydrarthrosis

Search GEO for disease gene expression data for Hydrarthrosis.

Pathways for Hydrarthrosis

Pathways related to Hydrarthrosis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.63 AQP1 AQP3 AQP7 AQP9 ASIC2 ASIC3
2 11.71 C4A IL1B IL1RN
3
Show member pathways
11.53 ADAMTS5 IL1B MMP3
4
Show member pathways
11.44 AQP1 AQP3 AQP7 AQP9 MIP
5 11.18 IL1B IL1RN MMP3

GO Terms for Hydrarthrosis

Cellular components related to Hydrarthrosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.85 AQP1 AQP3 AQP7 AQP9 ASIC2 ASIC3
2 integral component of plasma membrane GO:0005887 9.43 AQP1 AQP7 AQP9 ASIC2 ASIC3 MIP
3 extracellular space GO:0005615 9.17 ADAMTS5 C4A IL1B IL1RN MMP13 MMP3

Biological processes related to Hydrarthrosis according to GeneCards Suite gene sharing:

(show all 17)
# Name GO ID Score Top Affiliating Genes
1 transmembrane transport GO:0055085 9.85 AQP1 AQP3 AQP7 AQP9 MIP
2 inflammatory response GO:0006954 9.84 C4A IL1B IL1RN MEFV
3 proteolysis GO:0006508 9.81 ADAMTS5 MMP13 MMP3 PRTN3
4 cytokine-mediated signaling pathway GO:0019221 9.78 IL1B IL1RN MMP3 PRTN3
5 extracellular matrix disassembly GO:0022617 9.61 ADAMTS5 MMP13 MMP3
6 odontogenesis GO:0042476 9.57 AQP1 AQP3
7 renal water homeostasis GO:0003091 9.56 AQP1 AQP3
8 cellular response to nitric oxide GO:0071732 9.52 AQP1 MMP3
9 cation transmembrane transport GO:0098655 9.5 AQP1 ASIC2 ASIC3
10 response to acidic pH GO:0010447 9.49 ASIC2 ASIC3
11 collagen catabolic process GO:0030574 9.43 MMP13 MMP3 PRTN3
12 sensory perception of sour taste GO:0050915 9.4 ASIC2 ASIC3
13 detection of mechanical stimulus involved in sensory perception GO:0050974 9.37 ASIC2 ASIC3
14 excretion GO:0007588 9.33 AQP3 AQP7 AQP9
15 glycerol transport GO:0015793 9.26 AQP1 AQP3 AQP7 AQP9
16 response to vitamin D GO:0033280 9.25 AQP3
17 water transport GO:0006833 9.02 AQP1 AQP3 AQP7 AQP9 MIP

Molecular functions related to Hydrarthrosis according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 metallopeptidase activity GO:0008237 9.65 ADAMTS5 MMP13 MMP3
2 metalloendopeptidase activity GO:0004222 9.61 ADAMTS5 MMP13 MMP3
3 sodium channel activity GO:0005272 9.49 ASIC2 ASIC3
4 cation channel activity GO:0005261 9.46 ASIC2 ASIC3
5 interleukin-1 receptor binding GO:0005149 9.4 IL1B IL1RN
6 ligand-gated sodium channel activity GO:0015280 9.37 ASIC2 ASIC3
7 channel activity GO:0015267 9.35 AQP1 AQP3 AQP7 AQP9 MIP
8 glycerol channel activity GO:0015254 9.33 AQP3 AQP7 AQP9
9 serine-type endopeptidase activity GO:0004252 9.32 MMP3 PRTN3
10 water transmembrane transporter activity GO:0005372 9.26 AQP1 AQP9
11 water channel activity GO:0015250 9.02 AQP1 AQP3 AQP7 AQP9 MIP

Sources for Hydrarthrosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....